Pascal Soriot
Chief Executive Officer, AstraZeneca · United Kingdom
Pascal Soriot is the CEO of AstraZeneca (AZN). Soriot is based in the United Kingdom. Soriot was born in 1959 in France and educated at École nationale vétérinaire d'Alfort and HEC Paris.
French-born pharmaceutical executive who joined AstraZeneca as CEO in October 2012. Previously served as Chief Operating Officer of Roche's pharmaceuticals division and CEO of Genentech. Has held senior management roles across multiple major pharmaceutical companies since joining the industry in 1986.
Recent developments
AI summary of recent coverageRecent coverage has focused on the collapse of AstraZeneca's proposed $400 billion merger with Bristol Myers, which prompted commentary on Soriot's strategic decision-making and the rationale behind abandoning the large-scale deal. Beyond the failed acquisition, coverage has also highlighted Soriot's efforts to address trial risks through artificial intelligence deployment, the company's major investment plans in China, and warnings about regulatory pressures in markets like Germany.
Summarized from the headlines below; see each source for the full story.
Key Facts
Source: Wikidata ↗- Born
- May 23, 1959 · France
- Citizenship
- France
- Education
- École nationale vétérinaire d'Alfort, HEC Paris
Our coverage
On CEOInsider
No feature yet. When we publish a feature, interview or cover story on Pascal Soriot, it will appear here — and tie into the news timeline.
Pascal Soriot: FAQ
- Who is Pascal Soriot?
- Pascal Soriot is the Chief Executive Officer of AstraZeneca, based in United Kingdom.
- What company does Pascal Soriot lead?
- Pascal Soriot is CEO of AstraZeneca.
- Where was Pascal Soriot educated?
- Pascal Soriot studied at École nationale vétérinaire d'Alfort, HEC Paris.